Summary
To evaluate the effect of intracoronary diltiazem on myocardial ischemia during percutaneous transluminal coronary angioplasty (PTCA), 38 patients were randomly assigned to receive inactive placebo (n = 19; group C) or a low dose (1 mg,n = 10; group D1), or a high dose (2 or 3mg,n = 9; group D2) of diltiazem in a double-blind manner. The agent was administered directly into the coronary artery via a balloon catheter following a control balloon inflation. Chest pain score (maximum, 10) and the magnitude of ischemic ST elevation on standard and intracoronary electrocardiograms (ECGs) during a balloon inflation were assessed in the control and posttreatment periods. After the administration of diltiazem, the chest pain score was significantly decreased in group D1 (control: 5.1 ± 3.6, posttreatment: 3.8 ± 3.1,P < 0.01) and group D2 (3.4 ± 2.5 vs 2.5 ± 2.0,P < 0.01), but not in group C (4.1 ± 3.1 vs 3.7 ± 3.3, difference not significant). The magnitude of ST elevation relative to the control on standard and intracoronary ECGs was significantly smaller in groups D1 and D2 than in group C (standard ECG; D1: 51.8 ± 10.6% of control, D2: 41.6 ± 28.7% vs C: 93.3 ± 15.6% and intracoronary ECG; D1: 47.1 ± 11.7% of control, D2: 27.5 ± 26.9% vs C: 94.6 ± 29.3%, allP < 0.01). Although systolic blood pressure decreased slightly in groups D1 and D2, there was no significant correlation between the change in ST elevation and the change in the rate-pressure product. Pretreatment with a small dose of intracoronary diltiazem attenuated myocardial ischemia during PTCA and this pretreatment may enable us to perform balloon inflation for a longer period.
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1186%2Fs12872-022-02823-2/MediaObjects/12872_2022_2823_Fig1_HTML.jpg)
References
Henry PD, Shuchleib R, Borda LJ, Roberts R, Williamson JR, Sobel BE (1978) Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res 43:372–380
Clark RE, Christlieb IY, Henry PD, Fischer AE, Nora JD, Williamson JR, Sobel BE (1979) Nifedipine: A myocardial protective agent. Am J Cardiol 44:825–831
Nayler WG, Ferrari R, Williams A (1980) Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46:242–248
Fleckenstein A, Fleckenstein-Grün G (1980) Cardiovascular protection by Ca antagonists. Eur Heart J 1 [Suppl B]:15–21
Nakayama M, Kikuchi Y, Senda Y, Yamada A, Koiwaya Y (1980) Myocardial blood flow following experimental coronary occlusion. Effect of diltiazem. Chest 78 [Suppl]: 205–209
Vatner SF, Hintze TH (1982) Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Circulation 66:579–588
Sashida H, Abiko Y (1986) Protective effect of diltiazem on ultrastructural alterations induced by coronary occlusion and reperfusion in dog hearts. J Moll Cell Cardiol 18:401–411
Bertrand ME, Dupuis BA, Lablanche JM, Tilmant PY, Thieuleux FA (1982) Coronary hemodynamics following intravenous or intracoronary injection of diltiazem in man. J Cardiovasc Pharmacol 4:695–699
Schanzenbächer P, Liebau G, Deeg P, Kochsiek K (1983) Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption. Am J Cardiol 51:712–717
Amende I, Simon R, Hood WP Jr, Hetzer R, Lichtlen PR (1983) Intracoronary nifedipine in human beings: Magnitude and time course of changes in left ventricular contraction/relaxation and coronary sinus blood flow. J Am Coll Cardiol 2:1141–1145
Simonetti I, Trivella MG, Michelassi C, Parodi O, De Nes DM, L'Abbate A (1986) Dose-response scrutiny of coronary vasodilation after intracoronary verapamil in man. A quantitative cineangiographic study. Eur Heart J 7:848–858
Vrolix MC, Sionis D, Piessens JH (1991) Coronary hemodynamics and coronary flow reserve after intracoronary diltiazem in humans. Am J Cardiol 68:1633–1637
Serruys PW, van den Brand M, Brower RW, Hugenholtz PG (1983) Regional cardioplegia and cardioprotection during transluminal angioplasty, which role for nifedipine? Eur Heart J 4 [Suppl C]:115–121.
Hanet C, Rousseau MF, Vincent MF, Lavenne-Pardonge E, Pouleur H (1987) Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol 59:1035–1040
Babbit DG, Perry JM, Forman MB (1988) Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 12:1377–1381
Amende I, Hernmann G, Simon R, Hood WP Jr, Wenzlaff P, Lichtlen PR (1990) Protective effects of pretreatment with nifedipine on myocardial ischemia and dysfunction. Cardiovasc Drugs Ther 4:887–892
Kober G, Kästner R, Hopf R, Kaltenbach M (1986) Die direkte myokardiale antiischämische Wirkung von Diltiazem beim Menschen. Z Kardiol 75:386–393
Kaltenbach M, Beyer J, Walter S, Klepzig H, Schmidts L (1984) Prolonged application of pressure in transluminal coronary angioplasty. Cathet Cardiovasc Diagn 10:213–219
Rosenthal SJ, Ginsburg R, Lamb IH, Baim DS, Schroeder JS (1980) Efficacy of diltiazem for control of symptoms of coronary arterial spasm. Am J Cardiol 46:1027–1032
Feldman RL, Pepine CJ, Whittle J, Conti CR (1982) Short- and long-term responses to diltiazem in patients with variant angina. Am J Cardiol 49:554–559
Strauss WE, McIntyre KM, Parisi AF, Shapiro W (1982) Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trial. Am J Cardiol 49:560–566
Hossack KF, Pool PE, Steele P, Crawford MH, De Maria AN, Cohen LS, Ports TA (1982) Efficacy of diltiazem in angina on effort: A multicenter trial. Am J Cardiol 49: 567–572
Pool PE, Seagren SC (1982) Long-term efficacy of diltiazem in chronic stable angina associated with atherosclerosis: Effect on treadmill exercise. Am J Cardiol 49: 573–577
Piessens J, Brzostek T, Stammen F, Vanhaecke J, Vrolix M, De Geest H (1989) Effect of intravenous diltiazem on myocardial ischemia occurring during percutaneous transluminal coronary angioplasty. Am J Cardiol 64: 1103–1107
Nonogi H, Hess OM, Ritter M, Bortone A, Corin WJ, Grimm J, Krayenbuehl HP (1988) Prevention of coronary vasoconstriction by diltiazem during dynamic exercise in patients with coronary artery disease. J Am Coll Cardiol 12:892–899
Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5:587–592
Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P (1986) Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation 74: 330–339
Sharma B, Seth L, Bisset JK, Dolan JR, Wyeth RP, Franciosa JA (1986) Significance of percutaneous intracoronary epicardial electrocardiography during coronary angioplasty in man. J Am Coll Cardiol 7 [Suppl A]:127
Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis L, Penta de Peppo A, Chiariello L, Gioffrè PA (1994) Ischemic preconditiioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 90:700–705
Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, Merchant S, Chan C, Letac B (1992) Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study. J Am Coll Cardiol 20:578–586
Serruys PW, Wyns W, van den Brand M, Meij S, Slager C, Schuurbiers JCH, Hugenholtz PG, Brower RW (1984) Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation 70:25–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saito, K., Nonogi, H., Goto, Y. et al. Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA. Heart Vessels 11, 92–99 (1996). https://doi.org/10.1007/BF01744509
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01744509